BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32253931)

  • 1. Lentiviral Gene Therapy for Familial Hemophagocytic Lymphohistiocytosis Type 3, Caused by
    Takushi SE; Paik NY; Fedanov A; Prince C; Doering CB; Spencer HT; Chandrakasan S
    Hum Gene Ther; 2020 Jun; 31(11-12):626-638. PubMed ID: 32253931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral
    Dettmer V; Bloom K; Gross M; Weissert K; Aichele P; Ehl S; Cathomen T
    Hum Gene Ther; 2019 Aug; 30(8):975-984. PubMed ID: 31032638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.
    Dettmer-Monaco V; Weißert K; Ammann S; Monaco G; Lei L; Gräßel L; Rhiel M; Rositzka J; Kaufmann MM; Geiger K; Andrieux G; Lao J; Thoulass G; Schell C; Boerries M; Illert AL; Cornu TI; Ehl S; Aichele P; Cathomen T
    J Allergy Clin Immunol; 2024 Jan; 153(1):243-255.e14. PubMed ID: 37595758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a large UNC13D gene duplication in a patient with familial hemophagocytic lymphohistiocytosis type 3.
    Hiejima E; Shibata H; Yasumi T; Shimodera S; Hori M; Izawa K; Kawai T; Matsuoka M; Kojima Y; Ohara A; Nishikomori R; Ohara O; Heike T
    Clin Immunol; 2018 Jun; 191():63-66. PubMed ID: 29596912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A platform for complementation and characterization of familial haemophagocytic lymphohistiocytosis 3 mutations.
    Elstak E; de Jong A; van der Sluijs P
    J Immunol Methods; 2011 Feb; 365(1-2):58-66. PubMed ID: 21182842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis.
    Shibata H; Yasumi T; Shimodera S; Hiejima E; Izawa K; Kawai T; Shirakawa R; Wada T; Nishikomori R; Horiuchi H; Ohara O; Ishii E; Heike T
    Blood; 2018 May; 131(18):2016-2025. PubMed ID: 29549174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.
    Crozat K; Hoebe K; Ugolini S; Hong NA; Janssen E; Rutschmann S; Mudd S; Sovath S; Vivier E; Beutler B
    J Exp Med; 2007 Apr; 204(4):853-63. PubMed ID: 17420270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative
    Galgano D; Soheili T; Voss M; Torralba-Raga L; Tesi B; Cichocki F; Andre I; Rettig J; Cavazzana M; Bryceson Y
    Front Immunol; 2020; 11():1154. PubMed ID: 32582217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD57
    Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T
    J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea.
    Seo JY; Song JS; Lee KO; Won HH; Kim JW; Kim SH; Lee SH; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Han DK; Kook H; Hwang TJ; Lyu CJ; Lee MJ; Kim JY; Park SS; Lim YT; Kim BE; Koh KN; Im HJ; Seo JJ; Kim HJ;
    Ann Hematol; 2013 Mar; 92(3):357-64. PubMed ID: 23180437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and atypical splicing mutation in a compound heterozygous UNC13D defect presenting in Familial Hemophagocytic Lymphohistiocytosis triggered by EBV infection.
    Alsina L; Colobran R; de Sevilla MF; Català A; Viñas L; Ricart S; Plaza AM; Lois S; Juan M; Pujol-Borrell R; Martinez-Gallo M
    Clin Immunol; 2014 Aug; 153(2):292-7. PubMed ID: 24825797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis.
    Yoon HS; Kim HJ; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Kim JY; Lim YT; Bae KW; Lee KO; Shin JS; Lee ST; Chung HS; Kim SH; Park CJ; Chi HS; Im HJ; Seo JJ
    Haematologica; 2010 Apr; 95(4):622-6. PubMed ID: 20015888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic Lymphohistiocytosis.
    Tiwari S; Hontz A; Terrell CE; Arumugam P; Carmo M; Risma K; Jordan M; Malik P
    Hum Gene Ther; 2016 Oct; 27(10):847-859. PubMed ID: 27471778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): A systematic review.
    Amirifar P; Ranjouri MR; Abolhassani H; Moeini Shad T; Almasi-Hashiani A; Azizi G; Moamer S; Aghamohammadi A; Yazdani R
    Pediatr Allergy Immunol; 2021 Jan; 32(1):186-197. PubMed ID: 32679608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency.
    Soheili T; Durand A; Sepulveda FE; Rivière J; Lagresle-Peyrou C; Sadek H; de Saint Basile G; Martin S; Mavilio F; Cavazzana M; André-Schmutz I
    Blood Adv; 2017 Dec; 1(27):2781-2789. PubMed ID: 29296930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D.
    Meeths M; Chiang SC; Wood SM; Entesarian M; Schlums H; Bang B; Nordenskjöld E; Björklund C; Jakovljevic G; Jazbec J; Hasle H; Holmqvist BM; Rajic L; Pfeifer S; Rosthøj S; Sabel M; Salmi TT; Stokland T; Winiarski J; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI; Bryceson YT
    Blood; 2011 Nov; 118(22):5783-93. PubMed ID: 21931115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 253-kb inversion and deep intronic mutations in UNC13D are present in North American patients with familial hemophagocytic lymphohistiocytosis 3.
    Qian Y; Johnson JA; Connor JA; Valencia CA; Barasa N; Schubert J; Husami A; Kissell D; Zhang G; Weirauch MT; Filipovich AH; Zhang K
    Pediatr Blood Cancer; 2014 Jun; 61(6):1034-40. PubMed ID: 24470399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Dutch mutation in UNC13D reveals an essential role of the C2B domain in munc13-4 function.
    Elstak ED; te Loo M; Tesselaar K; van Kerkhof P; Loeffen J; Grivas D; Hennekam E; Boelens JJ; Hoogerbrugge PM; van der Sluijs P; van Gijn ME; van de Corput L
    Pediatr Blood Cancer; 2012 Apr; 58(4):598-605. PubMed ID: 21755595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.
    Yang T; Chen R; Zhang M; Jing R; Geng J; Wei G; Luo Y; Xiao P; Hong R; Feng J; Fu S; Zhao H; Cui J; Huang S; Huang H; Hu Y
    Cell Transplant; 2024; 33():9636897231221887. PubMed ID: 38183241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.
    Cichocki F; Schlums H; Li H; Stache V; Holmes T; Lenvik TR; Chiang SC; Miller JS; Meeths M; Anderson SK; Bryceson YT
    J Exp Med; 2014 Jun; 211(6):1079-91. PubMed ID: 24842371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.